Radiation Oncology
  • Radiation Oncology
  • Photo of faculty discussion

    University of Maryland Department of Radiation Oncology

    Video overview about the University of Maryland Department of Radiation Oncology

    WATCH VIDEO
  • MPTC 2024

    Maryland Proton Treatment Center

    More Than 5,000 People Treated

    LEARN MORE
  • Doctor Hands
  • Edge Machine
  • Matt Ferris with Patient
  • Speaker at podium

    Radiation Oncology Symposium - Best of 2024

    A Review of the Latest Advancements and Research in Radiation Oncology

    REGISTER
Radiation Oncology

Give to this Department

University of Maryland Department of Radiation Oncology

Our Vision and Mission

As we move forward, our past present, and future can be summarized by our Departmental Vision and Mission Statement:

Inspired by our patients and driven by passion

To provide EXCELLENCE within our missions of patient care, research, education and community outreach through a passionate patient-centered focus. It is who we are, it is what we do, it is what leaves us feeling there is more work to be done at the end of each day, and it is what drives us towards greater achievements at the start of each day.

Radiation Oncology Specialists Button
Radiation Oncology Locations Button
Radiation Oncology Education Button
Radiation Oncology Research Button
Radiation Oncology Treatments Button
Radiation Oncology Patients 2 Button

Department Chair

William Regine 200 pix

William F. Regine, MD, FACR, FASTRO, FACRO
Isadore and Fannie Schneider Foxman Chair and Distinguished Professor
Department of Radiation Oncology

Special Programs and Events

Radiation Oncology Symposium - Best of 2024
January 9, 2025 
Learn More >

Hyperthermia Clinical Observer Program
Learn More >

About Us

Overview of the Department of Radiation Oncology

For more than 100 years, the University of Maryland Department of Radiation Oncology has been pioneering radiation treatment in cancer, advancing scientific knowledge, and providing state-of-the-art educational opportunities.

Whether patients live in Baltimore or travel from their homes around the world, they know that they will be receiving the finest care, from the most state-of-the-art technology to the skilled and compassionate healing offered by every member of the Radiation Oncology faculty and staff.

Our department manages every type of cancer, providing a depth of experience that makes the University of Maryland not only the right place to receive care, but an ideal place for a professional career as well. The extraordinary pace of our recent progress has resulted from intellectual synergy and a shared, relentless ambition to deliver the highest quality of care to patients.

Each site is staffed with University of Maryland School of Medicine faculty. This affiliation opens the door to leading-edge treatment modalities, cutting-edge clinical trials and expert collaboration and consultation with University of Maryland Greenebaum Comprehensive Cancer Center physicians. The Department’s focus on promoting translational research includes integration of our radiobiology, physics and clinical divisions, and other basic science departments. 

The Department of Radiation Oncology has consistently ranked among the top 10 of NRG Oncology’s main member sites worldwide in terms of patient enrollments for clinical trials, and ranks number three as of 2022. Our physicians, physicists and basic science researchers are nationally recognized leaders in discovering new and better ways to treat cancer with radiotherapy.


Latest Department News

Resting in the Uncomfortable - Nurse Practitioners Dr. Martha Francis and Sarah Somers Discuss Difficult Conversions During a Serious Illness on AANP Podcast "NP Pulse: The Voice of the Nurse Practitioner"

Radiation Oncologists named as 2024 "Top Docs" by Baltimore Magazine

Senior resident presentation at ASTRO 2024 on new study suggests how cancer patients who experience cognitive decline after radiation treatment for brain metastases may regain full neurocognitive function

Lead investigator Dr. Jason Molitoris reports on outcomes & de-escalating treatment for HPV–associated oropharynx squamous cell carcinoma

UMGCCC-led Phase 2 clinical trial shows benefit to reducing radiation to lymph nodes in the opposite side of the neck in patients with p16-positive oropharyngeal cancer

UMSOM Awarded $3.5 million in federal funding to expand medical countermeasures program


Patient Success Stories